Symbiosis develops a unique minimally invasive platform shaped in real-time to the patient's anatomy for heart valve replacement procedures.

The company's solution focuses on major challenge of anatomical variability between patients and within the same patient over time, by fitting existing valves in the market for every single patient, increasing their success rate and introducing them into untapped markets.Symbiosis first product is ValSync, the first minimally invasive personalized solution for valve replacement.